Members 2025-2028
Gitte Knudsen, Denmark, Past-president, Chair | Martien Kas, The Netherlands, President |
Mara Dierssen, Spain | Andreas Reif, Germany, President-elect |
Peter Falkai, Germany | James Rowe, United Kingdom |
Catherine Harmer, United Kingdom |
Composition
Its terms of reference are defined by Section 16 of the ECNP Constitution:
The Nominating Committee is appointed by the Executive Committee in office to nominate candidates for the future Executive Committee. The Nominating Committee is constituted of seven members of whom the chair should be the Past President and another member the President-Elect. At least three members must be recruited from outside the Executive Committee. Its members are not eligible for the Executive Committee.
The Nominating Committee will take into account the leadership experience, scientific standing, gender balance, diversity and the geographical distribution of members in coming to their recommendation for the officers and members of the Executive Committee. The Nominating Committee will solicit self-nominations for open EC positions.
Tasks
The task of a Nominating Committee member is to:
- Nominates candidates for the future Executive Committee (EC)
Time commitment
Once appointed, the committee solicits nominations from members and takes soundings from a wide circle of members and stakeholders, to put together a roster of potential candidates.
Criteria include whether candidates are an ECNP member in good standing, whether they have a conflict of interest (by, for example, holding office in a closely related European or international society), and the nature of their organisational and leadership capabilities.
The committee then shapes a final proposal, taking in consideration geographical balance (east/west, north/south), preclinical/clinical balance, and gender balance, as well as a balance between renewal (new members) and continuity (existing members).
This proposal is submitted to members by 15 May in the year the term of the Executive Committee ends and is ratified during the General Assembly. It can be challenged by vote at the General Assembly, if an alternative suggestion has been put forward by at least fifteen ordinary members at least two month prior to the General Assembly.
The Executive Committee can decide to invite experts on a ad-hoc basis. Experts have no voting rights.